8,663
Total Claims
$1.6M
Drug Cost
3,017
Beneficiaries
$516
Cost/Patient
Peer Comparison vs. 109,535 Physician Assistant providers
-28%
Cost per patient vs peers
$516 vs $719 avg
+167%
Brand preference vs peers
17.7% vs 6.7% avg
Brand vs Generic
82% generic
Brand: 1,537 claims · $1.4M
Generic: 7,126 claims · $181K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 866 | $886K |
| Rivaroxaban | 201 | $217K |
| Sacubitril/Valsartan | 104 | $119K |
| Evolocumab | 59 | $46K |
| Dapagliflozin Propanediol | 33 | $32K |
| Ticagrelor | 27 | $22K |
| Metoprolol Succinate | 901 | $22K |
| Empagliflozin | 25 | $18K |
| Ranolazine | 83 | $17K |
| Atorvastatin Calcium | 883 | $14K |
| Alirocumab | 16 | $12K |
| Prasugrel Hcl | 51 | $10K |
| Rosuvastatin Calcium | 292 | $10K |
| Icosapent Ethyl | 20 | $9,900 |
| Diltiazem Hcl | 217 | $9,655 |
Prescribing Profile
51
Unique Drugs
$1.3M
Patient Profile
75
Avg Age
46%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data